Tumor Necrosis Factorα Inhibits Contractions to Sympathetic Nerve Stimulation by a Nitric Oxide-Dependent Mechanism

Summary Abstract. Gram-negative sepsis and administration of tumor necrosis factorα (TNFα) are associated with hypotension and peripheral neuropathies suggestive of impaired sympathetic neurotransmission. We examined the effect of TNFα on the responses of the bovine pulmonary artery (BPA) to transmural sympathetic nerve stimulation (SNS). BPA contracted to SNS (0.5-32 Hz, 5-10 V, 2-msec duration, 2-msec delay) in a frequency-dependent manner. The contractions of the BPA to SNS were mediated by norepinephrine and activation of postsynaptic α1-adrenoceptors, since they were attenuated by prazosin. Maximum contraction of the BPA to SNS was significantly enhanced (148 ± 37% increase, n = 6) after inhibition of nitric oxide synthase with L-NG-monomethylarginine (LNMMA, 500 μM), an effect abrogated by L-arginine (1 mM). TNFα (0.0042, 0.042, and 0.42 μg/ml) selectively inhibited contractions of the BPA to SNS without affecting the contraction of the BPA to exogenous norepinephrine. In BPA incubated with LNMMA (5-500 μM), TNFα facilitated rather than inhibited SNS. TNFα increased the formation of amperiometrically measured free nitric oxide in bovine adrenal chromaffin cells in primary culture. The data show that in the absence of LNMMA, TNFα releases free nitric oxide from a sympathetic neuron and selectively inhibits the contractions of the BPA to SNS. In BPA in which nitric oxide synthase I is inhibited by LNMMA, TNFα amplifies the contractions to SNS, even in the absence of endothelium. Thus, TNFα can modify vascular smooth muscle tone by affecting SNS. TNFα inhibits SNS at the level of the neuron by a mechanism involving the L-arginine-nitric oxide pathway. TNFα-induced suppression of SNS and neurotransmission may contribute to the hypotension and peripheral neuropathy of sepsis.

[1]  J. Kolls,et al.  Tumor necrosis factor-alpha inhibits endothelium-dependent relaxation. , 1993, Journal of applied physiology.

[2]  T. Malinski,et al.  Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor , 1992, Nature.

[3]  B. Soliven,et al.  Tumor Necrosis Factor Modulates the Inactivation of Catecholamine Secretion in Cultured Sympathetic Neurons , 1992, Journal of neurochemistry.

[4]  H. Adams,et al.  EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin. , 1992, The American journal of physiology.

[5]  K. Okada,et al.  [Alterations in number of rabbit myocardial beta-adrenergic receptors in endotoxic shock: down regulation in hyperdynamic sepsis model and effects of cytokines administration]. , 1991, Kokyu to junkan. Respiration & circulation.

[6]  D. Crawley,et al.  Endogenous nitric oxide modulates adrenergic neural vasoconstriction in guinea‐pig pulmonary artery , 1991, British journal of pharmacology.

[7]  J. Parrillo,et al.  The effect of tumor necrosis factor on vascular smooth muscle. In vitro studies using rat aortic rings. , 1991, Chest.

[8]  E. Jaffe,et al.  Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. , 1991, Biochemical and biophysical research communications.

[9]  N. Wiklund,et al.  Modulation of neuroeffector transmission in the guinea pig pulmonary artery by endogenous nitric oxide , 1991, Neuroscience Letters.

[10]  J. Parratt,et al.  Evidence that an l‐arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin , 1991, British journal of pharmacology.

[11]  R. Busse,et al.  Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells , 1990, FEBS letters.

[12]  T. Mckenna,et al.  Prolonged exposure of rat aorta to low levels of endotoxin in vitro results in impaired contractility. Association with vascular cytokine release. , 1990, The Journal of clinical investigation.

[13]  L. Ignarro,et al.  NG-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Adams,et al.  hypotension: Implications for the involvement of nitric oxide , 2022 .

[15]  A. M. Lefer,et al.  Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. , 1989, The American journal of physiology.

[16]  E. Karwatowska-Prokopczuk,et al.  L-arginine inhibits noradrenaline release in sympathetically stimulated rabbit hearts. , 1989, Acta physiologica Scandinavica.

[17]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[18]  Steven P. Wilson,et al.  Purification of adrenal chromaffin cells on renografin gradients , 1987, Journal of Neuroscience Methods.

[19]  J. Shellito,et al.  Ethanol relaxes pulmonary artery by release of prostaglandin and nitric oxide. , 1993, Alcohol.

[20]  B. Beutler,et al.  The role of cachectin/TNF in endotoxic shock and cachexia. , 1988, Immunology today.

[21]  M. Lindenbaum,et al.  Use of isolated chromaffin cells to study basic release mechanisms. , 1983, Journal of the autonomic nervous system.